FrancophonIA/ELRC3.0 huggingface dataset:
English: The veterinary medicinal product can be used as part of a treatment strategy for the control of Flea Allergy Dermatitis (FAD).
Croatian: Veterinarsko - medicinski proizvod može se koristiti kao dio strategije liječenja u kontroli alergijskog dermatitisa uzrokovanih buhama.
English: Tablet strength (mg sarolaner)
Croatian: Jačina tablete (mg sarolanera)
English: Use appropriate combination of available strengths to achieve the recommended dose of 2-4 mg/kg.
Croatian: Upotrijebite odgovarajuću kombinaciju raspoloživih jačina tableta da bi postigli preporučenu dozu 2 do 4 mg/kg tjelesne težine.
English: Sarolaner was determined to have low clearance (0.12 ml/min/kg) and a moderate volume of distribution (2.81 l/kg).
Croatian: Sarolaner ima niski bubrežni klirens (0,12 ml/min/kg), te umjereni volumen raspodjele (2,81 L/kg).
English: Number of tablets to be administered
Croatian: Broj tableta koje treba primijeniti
English: Treatment should be continued until skin scrapings are negative on at least two consecutive occasions one month apart.
Croatian: Liječenje treba nastaviti sve dok testovi struganje kože nisu negativni, najmanje dva uzastopna puta, u roku od mjesec dana.
English: Parasites need to start feeding on the host to become exposed to sarolaner; therefore, the transmission of infectious parasite-borne diseases cannot be excluded.
Croatian: Paraziti moraju započeti hranjenje na domaćinu kako bi bili izloženi sarolaneru; stoga se prijenos zaraznih bolesti uzorkovanih parazitima ne može isključiti.
English: Puppies less than 8 weeks of age and/or dogs less than 1.3 kg bodyweight should not be treated unless so advised by a veterinarian.
Croatian: Štenci mlađi od 8 tjedana starosti i psi lakši od 1,3 kg tjelesne težine ne bi se trebali liječiti osim ako veterinar nije savjetovao drugačije.
English: In the absence of available data, treatment of puppies less than 8 weeks of age and/or dogs less than 1.3 kg bodyweight should be based on a benefit-risk assessment by the responsible veterinarian.
Croatian: U nedostatku dostupnih podataka, liječenje štenaca mlađih od 8 mjeseci starosti i lakših od 1,3 kg tjelesne težine trebalo bi bazirati procjeni koristi/rizika od strane odgovornog veterinara.
English: For the treatment of ear mite infestations (Otodectes cynotis) a single dose should be administered.
Croatian: Za liječenje infestacije ušnim grinjama (Otodectes cynotis) potrebno je primijeniti jednu dozu.
English: The safety of the veterinary medicinal product has not been established during pregnancy and lactation or in animals intended for breeding.
Croatian: Neškodljivost veterinarsko-medicinskog proizvoda nije utvrđena za vrijeme graviditeta, laktacije ili u životinja namijenjenim za rasplod.
English: For the treatment of demodicosis (caused by Demodex canis) the administration of a single dose once monthly for three consecutive months is efficacious and leads to a marked improvement of clinical signs.
Croatian: Za liječenje demodikoze (uzrokovane Demodex canis) učinkovita je primjena jedne doze jednom mjesečno,tri uzastopna mjeseca, koja dovodi do značajnog poboljšanja kliničkih znakova.
English: Shelf life of the veterinary medicinal product as packaged for sale: 30 months.
Croatian: Rok valjanosti veterinarsko-medicinskog proizvoda kad je zapakiran za prodaju: 2 godine.
English: For each strength, the chewable tablets are available in a carton with 1 blister of 3 tablets.
Croatian: Tablete za žvakanje dostupne su za svaku jačinu u: kartonu s 1 blisterom od 3 tablete.
English: A further veterinary examination 30 days after treatment is recommended as some animals may require a second treatment.
Croatian: S obzirom da je nekim životinjama potrebno ponovno liječenje, preporučuje se veterinarski pregled 30 dana nakon liječenja.
English: Do not use this veterinary medicinal product after the expiry date which is stated on the blister after EXP.
Croatian: Ne koristite veterinarsko-medicinski proizvod poslije isteka roka valjanosti naznačenog na blisteru.
English: Appropriate combination of tablets
Croatian: Primjerena kombinacija tableta
English: The blister pack should be returned into the carton immediately after use and the carton should be stored out of the sight and reach of children.
Croatian: Odmah nakon uporabe blister treba biti vraćen u kutiju, a kutiju treba čuvati izvan pogleda i dosega djece.
English: In case of accidental ingestion, seek medical advice immediately and show the package leaflet or label to the physician.
Croatian: U slučaju nehotičnog gutanja, hitno zatražiti savjet liječnika i pokazati mu naljepnicu ili uputu o veterinarsko - medicinskom proizvodu.
English: Sarolaner was dose proportional in Beagle dogs when dosed from the intended use dose of 2-4 mg/kg, to 20 mg/kg.
Croatian: Sarolaner je bio proporcionalan danoj dozi kod pasa pasmine Beagle, kod doziranja propisane doze od 2 do 4 mg/kg pa do doze 20 mg/kg tjelesne težine.
English: PARTICULARS TO APPEAR ON THE OUTER PACKAGE CARTON
Croatian: PODACI KOJI SE MORAJU NALAZITI NA VANJSKOM PAKOVANJU
English: Hypromellose acetate succinate, medium grade Lactose monohydrate
Croatian: Hipromeloza acetat sukcinat, srednje kvalitete Laktoza monohidrat
English: 1348 Louvain-la-Neuve BELGIUM
Croatian: Zoetis Belgium SA Rue Laid Burniat, 1 1348 Louvain-la-Neuve BELGIJA
English: In a margin of safety study, the veterinary medicinal product was administered orally to 8 week old Beagle puppies at doses of 0, 1, 3, and 5 times the maximum exposure dose of 4 mg/kg at 28 day intervals for 10 doses.
Croatian: U granicama istraživanja neškodljivosti, veterinarsko - medicinski proizvod primjenjivao se peroralno štencima starim 8 tjedana pasmine Beagle u dozi 0, 1, 3 i 5 puta većoj od najveće preporučene doze, (4 mg/kg tjelesne težine) kroz 28 dana u 10 doza.
English: Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Croatian: Ne primjenjivati u slučajevima preosjetljivosti na djelatnu tvar, ili na bilo koju od pomoćnih tvari.
English: Sarolaner does not interact with known insecticidal binding sites of nicotinic or other GABAergic insecticides such as neonicotinoids, fiproles, milbemycins, avermectins, and cyclodienes.
Croatian: Sarolaner ne djeluje s poznatim mjestima vezanja nikotinskih i drugih GABAergičnih insekticida kao što su neonikotinoidi, fiproles, milbemicini, avermektini i ciklodieni.
English: The tablets should not be divided.
Croatian: Ne razdjeljivati tablete.
English: Sarolaner is highly bound to plasma proteins and might compete with other highly bound drugs such as non-steroidal anti-inflammatory drugs (NSAIDs) and the cumarin derivative warfarin.
Croatian: Sarolaner je snažno vezan uz proteine plazme te se može natjecati s drugim snažno vezanim lijekovima, kao što su nesteroidni protuupalni lijekovi (NSAID) i derivati kumarin varfarina.
English: The primary target of action of sarolaner in insects and acarines is functional blockade of ligand-gated chloride channels (GABA-receptors and glutamate-receptors).
Croatian: Primarni cilj djelovanja sarolanera kod insekata i grinja jest funkcionalna blokada o ligandu ovisnih kloridnih kanala (GABA receptori i receptori glutamata).
English: In the overdose groups, transient and self-limiting neurological signs were observed in some animals: mild tremors at 3 times the maximum exposure dose and convulsions at 5 times the maximum exposure dose.
Croatian: U grupi pasa s prekomjernim doziranjem, kod nekih su životinja primijećeni prolazni i samoograničavajući neurološki simptomi: blaga drhtavica mišića pri 3 puta većoj dozi i grčevi pri 5 puta većoj dozi od najveće preporučene doze.
English: The veterinary medicinal product has immediate and persistent tick killing activity for at least 5 weeks.
Croatian: Veterinarsko - medicinski proizvod ima trenutno i postojano djelovanje ubijanja krpelja najmanje 5 tjedana.
English: Mild and transient gastrointestinal signs such as vomiting and diarrhoea, transient neurological disorders such as tremor, ataxia or convulsion and systemic disorders such as lethargy, anorexia/inappetence may occur in very rare cases.
Croatian: U vrlo rijetkim slučajevima mogu se pojaviti blagi i prolazni gastrointestinalni simptomi kao što su povraćanje i proljev, prolazni neurološki poremećaji kao što su tremor, ataksija ili konvulzija i sustavni poremećaji kao što su letargija, anoreksija /inapetencija.
English: Mottled brown coloured, square shaped chewable tablets with rounded edges.
Croatian: Tablete za žvakanje obojene smeđom bojom, kvadratnog oblika sa zaobljenim rubovima.
English: Disruption of these receptors by sarolaner prevents the uptake of chloride ions by GABA and glutamate gated ion channels, thus resulting in increased nerve stimulation and death of the target parasite.
Croatian: Ometanje djelovanja receptora, koje uzrokuje sarolaner sprječava protok kloridnih iona preko GABA i glutamatnih ionskih kanala, što rezultira povećanom živčanom stimulacijom i smrti ciljnih parazita.
English: The primary route of elimination is biliary excretion of parent molecule, with elimination through the faeces.
Croatian: Glavni put izlučivanja matične molekule je sa žuči u izmetu.
English: For the treatment of ear mite infestations (Otodectes cynotis).
Croatian: Za liječenje infestacije ušnim grinjama (Otodectes cynotis).
English: For the treatment of flea infestations (Ctenocephalides felis and Ctenocephalides canis).
Croatian: Za liječenje i prevenciju infestacije buhama (Ctenocephalides felis i Ctenocephalides canis).
English: For the treatment of sarcoptic mange (caused by Sarcoptes scabiei var. canis) a single dose should be administered at monthly intervals for two consecutive months.
Croatian: Za liječenje sarkoptes šuge (uzrokovane Sarcoptes scabiei var. canis) treba davati jednu dozu na mjesečnoj bazi, dva mjeseca uzastopno.
English: Use only accordingly to the benefit-risk assessment by the responsible veterinarian.
Croatian: Kod životinja u vrijeme graviditeta i laktacije upotrijebiti samo u skladu s procjenom koristi/rizika od strane odgovornog veterinara.
English: Calcium hydrogen phosphate anhydrous
Croatian: Bezvodni kalcij hidrogen fosfat
English: For ticks (I. ricinus), the onset of efficacy is within 12 hours of attachment during the 28 day period after product administration.
Croatian: Kod krpelja (I. ricinus) početak učinkovitosti veterinarsko - medicinskog proizvoda je unutar 12 sati od primjene proizvoda u trajanju od 28 dana.
English: Sarolaner is well tolerated in Collies with a deficient multidrug-resistance-protein 1 (MDR1 -/-) following single oral administration at 5 times the recommended dose.
Croatian: Collies s nedovoljnim MDR 1-/- (multidrug-resistance-protein 1) dobro su podnijeli sarolaner prilikom jednokratne peroralne primjene 5 puta veće doze od preporučene.
English: The veterinary medicinal product kills newly emerged fleas on the dogs before they can lay eggs and therefore it prevents environmental flea contamination in areas to which the dog has access.
Croatian: Veterinarsko - medicinski proizvod ubija buhe koje dođu na psa prije nego što stignu izvaliti jajašca, te na taj način sprječava kontaminaciju buhama u područjima u kojima pas ima pristup.
English: MiPet Easecto tablets are chewable and palatable and readily consumed by dogs when offered by the owner.
Croatian: Tablete MiPet Easecto su ukusne za žvakanje zato ih psi rado uzimaju od vlasnika.
English: 3 tablets
Croatian: VELIČINA PAKOVANJA 3 tablete
English: PACKAGE LEAFLET: MiPet Easecto chewable tablets for dogs
Croatian: UPUTA O VMP MiPet Easecto tablete za žvakanje za pse
English: PSUR submissions for MiPet Easecto shall be synchronised and submitted at the same frequency as for Simparica.
Croatian: OSTALI UVJETI I ZAHTJEVI ODOBRENJA ZA STAVLJANJE U PROMET PSUR podnesci za MiPet Easecto sinkronizirat će se i podnositi jednakom učestalošću kao i za Simparicu.
English: The veterinary medicinal product has immediate and persistent flea killing activity against new infestations for at least 5 weeks.
Croatian: Veterinarsko - medicinski proizvod ima trenutno i postojano djelovanje ubijanja buha i sprječavanja novih infestacija najmanje 5 tjedana.
English: Sarolaner is active against adult fleas (Ctenocephalides felis and Ctenocephalides canis) as well as several tick species such as Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus, Rhipicephalus sanguineus and the mites Demodex canis, Otodectes cynotis and Sarcoptes scabiei.
Croatian: Sarolaner djeluje na odrasle buhe (Ctenocephalides felis i Ctenocephalides canis) te na brojne vrste krpelja Dermacentor reticulatus, Dermacentor variabilis, Ixodes hexagonus, Ixodes holocyclus, Ixodes ricinus, Ixodes scapularis, Rhipicephalus sanguineus i grinja Demodex canis, Otodectes cynotis te Sarcoptes scabiei.
English: Wheat germ
Croatian: Pšenična klica
English: For the treatment of tick infestations (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus and Rhipicephalus sanguineus).
Croatian: Za liječenje infestacije krpeljima (Dermacentor reticulatus, Ixodes hexagonus, Ixodes ricinus i
English: Aluminium foil/foil blister package.
Croatian: Aluminijski blister.
English: In laboratory safety studies, no interactions were observed when sarolaner was co-administered with milbemycin oxime, moxidectin and pyrantel pamoate.
Croatian: U laboratorijskim ispitivanjima neškodljivosti nisu primijećene interakcije prilikom paralelne upotrebe sarolanera i milbemicin oksima, moksidektina i pirantel pamoata (učinkovitost nije istražena u ovim ispitivanjima).
English: For fleas, the onset of efficacy is within 8 hours of attachment during the 28 day period after product administration.
Croatian: Kod buha početak učinkovitosti veterinarsko - medicinskog proizvoda je unutar 8 sati od primjene proizvoda u trajanju od 28 dana.
English: Sodium starch glycolate Silica, colloidal anhydrous Magnesium stearate
Croatian: Silicij, koloidni bezvodni Magnezijev stearat
English: Name and address of the manufacturer responsible for batch release
Croatian: Ime i adresa proizvođača odgovornog(ih) za puštanje serije u promet
English: Sarolaner exhibits higher functional potency to block insect/acarine receptors compared to mammalian receptors.
Croatian: Sarolaner ima veći afinitet za funkcionalnu blokadu receptora insekata i grinja nego receptora sisavaca.
English: Sarolaner blocks GABA- and glutamate-gated chloride channels in the central nervous system of insects and acarines.
Croatian: Sarolaner inhibira GABA receptore i receptore glutamata u centralnom živčanom sustavu insekata i grinja.
English: For optimal control of flea and tick infestations, the veterinary medicinal product should be administered at monthly intervals and continue throughout the flea and/or tick season based on the local epidemiological situation.
Croatian: Za optimalnu kontrolu infestacije buhama i krpeljima, veterinarsko - medicinski proizvod treba davati na mjesečnoj bazi.
English: MiPet Easecto 5 mg chewable tablets for dogs 1.3-2.5 kg MiPet Easecto 10 mg chewable tablets for dogs >2.5-5 kg MiPet Easecto 20 mg chewable tablets for dogs >5-10 kg MiPet Easecto 40 mg chewable tablets for dogs >10-20 kg MiPet Easecto 80 mg chewable tablets for dogs >20-40 kg MiPet Easecto 120 mg chewable tablets for dogs >40-60 kg
Croatian: MiPet Easecto 5 mg tablete za žvakanje za pse 1,3 - 2,5 kg MiPet Easecto 10 mg tablete za žvakanje za pse > 2,5 - 5 kg MiPet Easecto 20 mg tablete za žvakanje za pse > 5 - 10 kg MiPet Easecto 40 mg tablete za žvakanje za pse > 10 - 20 kg MiPet Easecto 80 mg tablete za žvakanje za pse > 20 - 40 kg MiPet Easecto 120 mg tablete za žvakanje za pse > 40 - 60 kg
English: The accidental ingestion of the product may potentially result in adverse effects, such as transient excitatory neurological signs.
Croatian: Slučajno gutanje proizvoda može dovesti do neželjenih učinaka.
English: MiPet Easecto 5 mg chewable tablets for dogs 1.3-2.5 kg MiPet Easecto 10 mg chewable tablets for dogs >2.5-5 kg MiPet Easecto 20 mg chewable tablets for dogs >5-10 kg MiPet Easecto 40 mg chewable tablets for dogs >10-20 kg MiPet Easecto 80 mg chewable tablets for dogs >20-40 kg MiPet Easecto 120 mg chewable tablets for dogs >40-60 kg sarolaner
Croatian: MiPet Easecto 5 mg tablete za žvakanje za pse 1,3 - 2,5 kg MiPet Easecto 10 mg tablete za žvakanje za pse > 2,5 - 5 kg MiPet Easecto 20 mg tablete za žvakanje za pse > 5 - 10 kg MiPet Easecto 40 mg tablete za žvakanje za pse > 10 - 20 kg MiPet Easecto 80 mg tablete za žvakanje za pse > 20 - 40 kg MiPet Easecto 120 mg tablete za žvakanje za pse > 40 - 60 kg sarolaner
English: Glucose, liquid (81.5% solids) Spray dried pork liver powder Hydrolysed vegetable protein Gelatin type A
Croatian: Hidrolizirani biljni protein Želatina tip A
English: for dogs 1.3-2.5 kg for dogs >2.5-5 kg for dogs >5-10 kg for dogs >10-20 kg for dogs >20-40 kg for dogs >40-60 kg
Croatian: za pse 1,3 - 2,5 kg za pse > 2,5 - 5 kg za pse > 5 - 10 kg za pse > 10 - 20 kg za pse > 20 - 40 kg za pse > 40 - 60 kg
English: Confectioner's sugar
Croatian: Natrijev škrobglikolat
English: EXPIRY DATE
Croatian: SAŽETAK OPISA SVOJSTAVA
English: Further information on Ziextenzo can be found on the Agency's website: https://www.ema.europa.eu/en/medicines/human/EPAR/ziextenzo.
Croatian: Više informacija o lijeku Ziextenzo nalazi se na internetskim stranicama Agencije: https://www.ema.europa.eu/en/medicines/human/EPAR/ziextenzo
English: Neutropenia lasted 1 day on average with both medicines.
Croatian: Neutropenija je u prosjeku trajala 1 dan uz oba lijeka.
English: Filgrastim has been available in other medicines in the European Union (EU) for a number of years.
Croatian: Filgrastim je već godinama dostupan u drugim lijekovima u Europskoj uniji (EU).
English: What measures are being taken to ensure the safe and effective use of Ziextenzo?
Croatian: Koje se mjere poduzimaju kako bi se osigurala sigurna i učinkovita primjena lijeka Ziextenzo?
English: The most common side effect with Ziextenzo (which may affect more than 1 in 10 people) is pain in the bones.
Croatian: Najčešća nuspojava lijeka Ziextenzo (koja se može javiti u više od 1 na 10 osoba) jest bol u kostima.
English: This means that Ziextenzo is highly similar to another biological medicine (the ‘reference medicine') that is already authorised in the EU.
Croatian: To znači da je Ziextenzo vrlo sličan drugom biološkom lijeku („referentnom lijeku”) koji je već odobren u EU-u.
English: Side effects reported with Ziextenzo are carefully evaluated and any necessary action taken to protect patients.
Croatian: Nuspojave prijavljene za lijek Ziextenzo pažljivo se procjenjuju i poduzimaju se potrebne mjere za zaštitu bolesnika.
English: Ziextenzo is a ‘biosimilar medicine'.
Croatian: Ziextenzo je „biosličan lijek”.
English: Ziextenzo is given as a single dose of 6 mg injected under the skin at least 24 hours after the end of each cycle of chemotherapy (treatment with cancer medicines).
Croatian: Ziextenzo se daje kao pojedinačna doza od 6 mg koja se ubrizgava ispod kože najmanje 24 sata nakon završetka svakog ciklusa kemoterapije (terapije protiv raka).
English: What is Ziextenzo and what is it used for?
Croatian: Što je Ziextenzo i za što se primjenjuje?
English: An overview of Ziextenzo and why it is authorised in the EU
Croatian: Pregled informacija o lijeku Ziextenzo i zašto je odobren u EU-u
English: The reference medicine for Ziextenzo is Neulasta.
Croatian: Referentni lijek za Ziextenzo je Neulasta.
English: The European Medicines Agency decided that, in accordance with EU requirements for biosimilar medicines, Ziextenzo has a highly similar structure, purity and biological activity to Neulasta and is distributed in the body in the same way.
Croatian: Europska agencija za lijekove zaključila je da, u skladu sa zahtjevima EU-a za bioslične lijekove, lijek Ziextenzo ima vrlo sličnu strukturu, čistoću i biološku aktivnost kao i lijek Neulasta te se u tijelu raspoređuje na isti način.
English: Ziextenzo can only be obtained with a prescription and treatment should be started and supervised by a doctor who has experience in the treatment of cancer or blood disorders.
Croatian: Lijek Ziextenzo izdaje se samo na liječnički recept, a terapiju mora započeti i pratiti liječnik s iskustvom u liječenju raka ili poremećaja krvi.
English: What are the risks associated with Ziextenzo?
Croatian: Koji su rizici povezani s lijekom Ziextenzo?
English: Why is Ziextenzo authorised in the EU?
Croatian: Zašto je lijek Ziextenzo odobren u EU-u?
English: Because Ziextenzo is a biosimilar medicine, the studies on effectiveness and safety of pegfilgrastim carried out with Neulasta do not all need to be repeated for Ziextenzo.
Croatian: Budući da je lijek Ziextenzo biosličan lijek, ispitivanja djelotvornosti i sigurnosti primjene pegfilgrastima provedena za lijek Neulasta nije potrebno ponavljati za lijek Ziextenzo.
English: Other information about Ziextenzo
Croatian: Ostale informacije o lijeku Ziextenzo
English: It is given specifically to reduce the duration of neutropenia and prevent febrile neutropenia (when neutropenia is accompanied by fever).
Croatian: Primjenjuje se isključivo za skraćivanje trajanja neutropenije i sprječavanje febrilne neutropenije (neutropenije popraćene vrućicom).
English: Recommendations and precautions to be followed by healthcare professionals and patients for the safe and effective use of Ziextenzo have been included in the summary of product characteristics and the package leaflet.
Croatian: Preporuke i mjere opreza kojih se zdravstveni radnici i bolesnici trebaju pridržavati u cilju sigurne i učinkovite primjene lijeka Ziextenzo nalaze se u sažetku opisa svojstava i u uputi o lijeku.
English: Therefore, the Agency's view was that, as for Neulasta, the benefit of Ziextenzo outweighs the identified risk and it can be authorised for use in the EU.
Croatian: Stoga je stav Agencije da korist od lijeka Ziextenzo, kao i od lijeka Neulasta, nadmašuje identificirani rizik te da lijek može biti odobren za primjenu u EU-u.
English: The safety of Ziextenzo has been evaluated, and on the basis of all the studies carried out the side effects of the medicine are considered to be comparable to those of the reference medicine Neulasta.
Croatian: Ocijenjena je sigurnost primjene lijeka Ziextenzo i na temelju svih provedenih ispitivanja nuspojave lijeka smatraju se usporedivima s onima za referentni lijek Neulasta.
English: In addition, two studies involving 624 patients who had chemotherapy before or after surgery for breast cancer showed that Ziextenzo was as effective as Neulasta in reducing the duration of neutropenia.
Croatian: Nadalje, ispitivanje koje je obuhvaćalo 624 bolesnika koji su prošli kemoterapiju prije ili nakon kirurškog zahvata zbog raka dojke pokazalo je da je Ziextenzo jednako djelotvoran kao Neulasta u smanjivanju trajanja neutropenije.
English: Ziextenzo is not intended for use in patients with the blood cancer chronic myeloid leukaemia or with myelodysplastic syndromes (conditions in which large numbers of abnormal blood cells are produced, which can develop into leukaemia).
Croatian: Ziextenzo nije namijenjen za primjenu u bolesnika s rakom krvi, kroničnom mijeloičnom leukemijom i mijelodisplastičnim sindromima (stanjima kod kojih se stvara veliki broj abnormalnih krvnih stanica, koja se mogu razviti u leukemiju).
English: As for all medicines, data on the use of Ziextenzo are continuously monitored.
Croatian: Kao i za sve lijekove, podatci o primjeni lijeka Ziextenzo kontinuirano se prate.
English: The active substance in Ziextenzo, pegfilgrastim, is a form of filgrastim, which is very similar to a human protein called granulocyte-colony-stimulating factor (G-CSF).
Croatian: Djelatna tvar u lijeku Ziextenzo, pegfilgrastim, sastoji se od filgrastima, koji je vrlo sličan ljudskoj bjelančevini naziva faktor stimulacije rasta kolonije granulocita (G-CSF).
English: For more information about using Ziextenzo, see the package leaflet or contact your doctor or pharmacist.
Croatian: Više informacija o primjeni lijeka Ziextenzo pročitajte u uputi o lijeku, odnosno obratite se liječniku ili ljekarniku.
English: What benefits of Ziextenzo have been shown in studies?
Croatian: Koje su koristi od lijeka Ziextenzo utvrđene u ispitivanjima?